GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Lbp | increases expression | EXP | | 6480464 | CTD | Lipopolysaccharides results in increased expression of LBP mRNA | PMID:16309824 | Lbp | affects binding | ISO | LBP (Homo sapiens) | 6480464 | CTD | Lipopolysaccharides binds to LBP protein | PMID:19540866 PMID:21261300 | Lbp | increases expression | ISO | LBP (Homo sapiens) | 6480464 | CTD | Lipopolysaccharides results in increased expression of LBP protein | PMID:20699433 | Lbp | increases expression | ISO | Lbp (Mus musculus) | 6480464 | CTD | Lipopolysaccharides results in increased expression of LBP mRNA | PMID:27339419 | Lbp | increases response to substance | ISO | LBP (Homo sapiens) | 6480464 | CTD | LBP polymorphism results in increased susceptibility to Lipopolysaccharides | PMID:22167001 | Lbp | multiple interactions | ISO | LBP (Homo sapiens) | 6480464 | CTD | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LBP mRNA; Ketamine inhibits the reaction [Lipopolysaccharides binds to LBP protein] | PMID:19540866 PMID:35811015 | |
Go Back to source page | Continue to Ontology report |